PSTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.20%

Insider Buying (Last 12 Months): $8,024,999.50

Insider Selling (Last 12 Months): $592,968.24

Poseida Therapeutics Insider Trading History Chart

Poseida Therapeutics Share Price & Price History

^$4.10

▲ +0.05 (1.23%)

As of 03/22/2023 09:34 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Poseida Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2022	Eric Ostertag	Chairman	Buy	142,857	$3.50	$499,999.50	838,824
8/8/2022	Life Sciences Holdings L Malin	Major Shareholder	Buy	2,150,000	$3.50	$7,525,000.00	11,835,673
8/3/2022	Eric Ostertag	Chairman	Sell	160,696	$3.69	$592,968.24	695,967
3/16/2022	Kerry D. Ingalls	COO	Buy	3,000	$3.98	$11,940.00
12/6/2021	Life Sciences Holdings L Malin	Director	Buy	1,828	$6.90	$12,613.20
12/1/2021	Life Sciences Holdings L Malin	Director	Buy	18,365	$6.85	$125,800.25
11/29/2021	Life Sciences Holdings L Malin	Director	Buy	11,057	$6.89	$76,182.73
11/26/2021	Life Sciences Holdings L Malin	Director	Buy	27,251	$6.81	$185,579.31
11/23/2021	Life Sciences Holdings L Malin	Director	Buy	14,625	$6.77	$99,011.25
11/18/2021	Life Sciences Holdings L Malin	Director	Buy	71,312	$7.18	$512,020.16
11/17/2021	Kerry D. Ingalls	COO	Buy	2,000	$7.00	$14,000.00
11/16/2021	Life Sciences Holdings L Malin	Director	Buy	27,680	$7.17	$198,465.60
11/8/2021	Eric Ostertag	CEO	Sell	18,924	$7.09	$134,171.16
10/1/2021	Eric Ostertag	CEO	Sell	20,029	$7.02	$140,603.58
9/20/2021	Eric Ostertag	CEO	Sell	20,000	$8.00	$160,000.00
9/14/2021	Eric Ostertag	CEO	Sell	20,000	$8.14	$162,800.00
8/20/2021	Matthew A. Spear	Insider	Sell	4,000	$8.79	$35,160.00	45,485
7/1/2021	Eric Ostertag	CEO	Sell	20,563	$9.77	$200,900.51
6/11/2021	Matthew A. Spear	Insider	Sell	4,000	$9.44	$37,760.00	20,485
6/1/2021	Eric Ostertag	CEO	Sell	41,194	$8.61	$354,680.34	542,985
5/3/2021	Eric Ostertag	CEO	Sell	18,326	$9.01	$165,117.26	542,985
4/21/2021	Matthew A. Spear	Insider	Sell	4,000	$8.44	$33,760.00	15,485
4/5/2021	Eric Ostertag	CEO	Sell	57,819	$9.66	$558,531.54	542,985
4/1/2021	Eric Ostertag	CEO	Sell	57,181	$9.55	$546,078.55	542,985
2/16/2021	Eric Ostertag	CEO	Sell	133,149	$10.00	$1,331,490.00	431,590
2/10/2021	Eric Ostertag	CEO	Sell	12,389	$10.00	$123,890.00	431,590
1/21/2021	Eric Ostertag	CEO	Sell	4,462	$10.00	$44,620.00	364,056
7/14/2020	Sean Murphy	Director	Buy	10,000	$16.00	$160,000.00	10,000

Stocks Positioned For The Year

From PressReach | Ad

This breakthrough stock has bright future this decade.

Learn more today.

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.67% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Poseida Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/16/2023	State of Wyoming	7,146	$38K	0.0%	N/A	0.008%
2/15/2023	Jane Street Group LLC	70,353	$0.37M	0.0%	N/A	0.082%
2/15/2023	Lazard Asset Management LLC	16,944	$89K	0.0%	N/A	0.020%
2/15/2023	Virtu Financial LLC	17,789	$94K	0.0%	N/A	0.021%
2/15/2023	Silverarc Capital Management LLC	2,230,000	$11.82M	3.4%	-12.7%	2.595%
2/15/2023	Susquehanna Fundamental Investments LLC	10,447	$55K	0.0%	N/A	0.012%
2/15/2023	Millennium Management LLC	1,646,897	$8.73M	0.0%	+984.9%	1.916%
2/15/2023	Morgan Stanley	106,087	$0.56M	0.0%	+52.7%	0.123%
2/15/2023	Man Group plc	27,663	$0.15M	0.0%	+130.2%	0.032%
2/15/2023	EAM Investors LLC	218,305	$1.16M	0.2%	N/A	0.254%
2/15/2023	Atom Investors LP	33,175	$0.18M	0.1%	-78.2%	0.039%
2/15/2023	Boothbay Fund Management LLC	17,142	$91K	0.0%	N/A	0.020%
2/14/2023	Verition Fund Management LLC	13,500	$72K	0.0%	N/A	0.016%
2/14/2023	683 Capital Management LLC	36,966	$0.20M	0.0%	N/A	0.043%
2/14/2023	Marshall Wace LLP	511,404	$2.71M	0.0%	N/A	0.595%
2/14/2023	Two Sigma Investments LP	66,185	$0.35M	0.0%	+115.0%	0.077%
2/14/2023	Penserra Capital Management LLC	28,590	$0.15M	0.0%	-60.1%	0.033%
2/13/2023	Charles Schwab Investment Management Inc.	264,577	$1.40M	0.0%	+2.0%	0.308%
2/13/2023	Callan Capital LLC	62,347	$0.33M	0.0%	N/A	0.073%
2/13/2023	Barclays PLC	58,109	$0.31M	0.0%	+84.7%	0.068%
2/13/2023	Renaissance Technologies LLC	196,300	$1.04M	0.0%	-42.8%	0.228%
2/13/2023	Geode Capital Management LLC	491,472	$2.60M	0.0%	+8.0%	0.572%
2/13/2023	GSA Capital Partners LLP	95,469	$0.51M	0.1%	N/A	0.111%
2/13/2023	Knott David M Jr	168,839	$0.90M	0.3%	+11.6%	0.196%
2/13/2023	JPMorgan Chase & Co.	31,224	$0.17M	0.0%	-72.4%	0.036%
2/10/2023	Bank of America Corp DE	18,696	$99K	0.0%	-28.9%	0.022%
2/10/2023	Creative Planning	10,800	$57K	0.0%	-46.8%	0.013%
2/10/2023	HRT Financial LP	200,351	$1.06M	0.0%	N/A	0.233%
2/10/2023	Blair William & Co. IL	19,143	$0.10M	0.0%	+8.5%	0.022%
2/9/2023	Dimensional Fund Advisors LP	276,419	$1.47M	0.0%	+128.6%	0.322%
2/9/2023	Citigroup Inc.	163,675	$0.87M	0.0%	+5,651.1%	0.190%
2/1/2023	Bank of Montreal Can	399,472	$1.62M	0.0%	-22.9%	0.465%
1/31/2023	MCF Advisors LLC	42,854	$0.23M	0.0%	-17.4%	0.050%
12/8/2022	Bank of New York Mellon Corp	49,468	$0.18M	0.0%	+181.7%	0.058%
11/15/2022	Two Sigma Investments LP	30,777	$0.11M	0.0%	N/A	0.036%
11/15/2022	Vanguard Group Inc.	2,384,866	$8.42M	0.0%	+79.9%	2.775%
11/15/2022	Perceptive Advisors LLC	750,000	$2.65M	0.1%	N/A	0.873%
11/15/2022	EcoR1 Capital LLC	2,650,000	$9.36M	0.3%	N/A	3.083%
11/15/2022	Bank of New York Mellon Corp	49,468	$0.18M	0.0%	+181.7%	0.058%
11/15/2022	BlackRock Inc.	1,447,918	$5.11M	0.0%	+29.7%	1.685%
11/14/2022	Pentwater Capital Management LP	5,975,000	$21.09M	0.2%	+20.3%	7.222%
11/14/2022	Cormorant Asset Management LP	1,850,000	$6.53M	0.5%	N/A	2.236%
11/14/2022	Cubist Systematic Strategies LLC	15,510	$55K	0.0%	N/A	0.019%
11/14/2022	Renaissance Technologies LLC	343,300	$1.21M	0.0%	-9.7%	0.415%
11/14/2022	Ergoteles LLC	93,842	$0.33M	0.0%	-31.2%	0.113%
11/14/2022	Penserra Capital Management LLC	71,587	$0.25M	0.0%	N/A	0.087%
11/14/2022	Crown Advisors Management Inc.	150,000	$0.53M	0.5%	N/A	0.181%
11/14/2022	Forefront Analytics LLC	15,650	$59K	0.0%	-33.0%	0.019%
11/10/2022	Dimensional Fund Advisors LP	120,943	$0.43M	0.0%	-16.6%	0.146%
11/10/2022	Bank of Montreal Can	517,900	$2.10M	0.0%	N/A	0.626%
11/9/2022	MCF Advisors LLC	51,854	$0.18M	0.0%	-13.1%	0.063%
11/8/2022	Atom Investors LP	152,120	$0.54M	0.2%	+172.5%	0.184%
11/4/2022	Prudential Financial Inc.	12,600	$44K	0.0%	N/A	0.015%
11/2/2022	DekaBank Deutsche Girozentrale	80,000	$0.26M	0.0%	N/A	0.097%
10/28/2022	Silverarc Capital Management LLC	2,554,277	$9.02M	3.0%	+571.1%	3.088%
8/18/2022	Goldman Sachs Group Inc.	44,715	$0.12M	0.0%	-20.8%	0.054%
8/16/2022	Corton Capital Inc.	14,978	$39K	0.0%	-74.2%	0.018%
8/16/2022	Delphia USA Inc.	15,799	$41K	0.0%	-61.2%	0.019%
8/15/2022	State Street Corp	92,967	$0.24M	0.0%	-82.5%	0.112%
8/15/2022	Citadel Advisors LLC	72,574	$0.19M	0.0%	+156.1%	0.088%
8/15/2022	Laurion Capital Management LP	545,700	$1.41M	0.0%	N/A	0.660%
8/15/2022	Millennium Management LLC	1,012,515	$2.61M	0.0%	+21.3%	1.224%
8/13/2022	Renaissance Technologies LLC	380,100	$0.98M	0.0%	+103.3%	0.606%
8/12/2022	Northern Trust Corp	50,246	$0.13M	0.0%	-79.0%	0.080%
8/12/2022	FMR LLC	9,405,708	$24.27M	0.0%	+0.3%	11.369%
8/11/2022	JPMorgan Chase & Co.	234,184	$0.60M	0.0%	-26.5%	0.373%
8/10/2022	Forefront Analytics LLC	23,370	$61K	0.0%	-12.7%	0.037%
7/25/2022	Silverarc Capital Management LLC	380,606	$0.98M	0.3%	+58.8%	0.607%
5/23/2022	Cantor Fitzgerald L. P.	30,205	$0.14M	0.0%	+19.8%	0.048%
5/17/2022	Delphia USA Inc.	40,733	$0.18M	0.1%	N/A	0.065%
5/16/2022	Goldman Sachs Group Inc.	56,477	$0.25M	0.0%	-27.5%	0.090%
5/16/2022	State Street Corp	531,573	$2.38M	0.0%	-2.3%	0.850%
5/16/2022	Prelude Capital Management LLC	11,250	$50K	0.0%	N/A	0.018%
5/13/2022	Silverarc Capital Management LLC	239,696	$1.07M	0.4%	+2.0%	0.383%
5/13/2022	Renaissance Technologies LLC	187,000	$0.84M	0.0%	+456.5%	0.299%
5/13/2022	Northern Trust Corp	239,289	$1.07M	0.0%	-5.0%	0.383%
5/13/2022	Charles Schwab Investment Management Inc.	220,090	$0.99M	0.0%	+3.9%	0.352%
5/13/2022	Vanguard Group Inc.	1,446,264	$6.48M	0.0%	-0.4%	2.312%
5/13/2022	Dimensional Fund Advisors LP	144,567	$0.65M	0.0%	+48.5%	0.231%
5/12/2022	BlackRock Inc.	2,468,954	$11.06M	0.0%	-3.3%	3.947%
5/12/2022	Martingale Asset Management L P	16,116	$73K	0.0%	-32.0%	0.026%
5/11/2022	JPMorgan Chase & Co.	318,676	$1.43M	0.0%	+7.0%	0.509%
5/9/2022	Forefront Analytics LLC	26,770	$0.12M	0.0%	+152.1%	0.043%
5/5/2022	MCF Advisors LLC	57,469	$0.26M	0.0%	N/A	0.092%
5/5/2022	Russell Investments Group Ltd.	9,407	$42K	0.0%	-66.6%	0.015%
4/29/2022	Nisa Investment Advisors LLC	13,000	$58K	0.0%	N/A	0.021%
4/19/2022	Regent Investment Management LLC	20,922	$94K	0.0%	-16.3%	0.033%
2/14/2022	Blair William & Co. IL	48,963	$0.33M	0.0%	N/A	0.078%
2/14/2022	GSA Capital Partners LLP	84,701	$0.58M	0.1%	N/A	0.136%
2/8/2022	Northern Trust Corp	251,793	$1.72M	0.0%	-2.0%	0.403%
2/2/2022	New York State Common Retirement Fund	11,972	$82K	0.0%	-42.1%	0.019%
1/21/2022	Russell Investments Group Ltd.	28,178	$0.19M	0.0%	-25.2%	0.045%
1/18/2022	Central Bank & Trust Co.	7,608	$52K	0.0%	+1,579.5%	0.012%
11/17/2021	Altium Capital Management LP	32,238	$0.24M	0.1%	N/A	0.052%
11/16/2021	Schonfeld Strategic Advisors LLC	289,179	$2.11M	0.0%	+13.6%	0.463%
11/16/2021	Millennium Management LLC	909,856	$6.63M	0.0%	-13.0%	1.456%
11/15/2021	Pura Vida Investments LLC	114,343	$0.83M	0.0%	-20.1%	0.183%
11/15/2021	Voya Investment Management LLC	13,813	$0.10M	0.0%	-87.9%	0.022%
11/15/2021	Martingale Asset Management L P	15,615	$0.11M	0.0%	N/A	0.025%
11/12/2021	Trexquant Investment LP	12,442	$91K	0.0%	N/A	0.020%

Data available starting January 2016

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $4.10

$4.10

50 Day Range

MA: $6.40

$3.89

$8.73

52 Week Range

Now: $4.10

$1.82

$8.82

Volume

242 shs

Average Volume

624,204 shs

Market Capitalization

$354.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Poseida Therapeutics?: Poseida Therapeutics' top insider shareholders include:
Life Sciences Holdings L Malin (Major Shareholder)
Eric Ostertag (Chairman)
Eric Ostertag (CEO)
Matthew A Spear (Insider)
Kerry D Ingalls (COO)
Life Sciences Holdings L Malin (Director)
Learn More about top insider investors at Poseida Therapeutics.
Who are the major institutional investors of Poseida Therapeutics?: Poseida Therapeutics' top institutional investors include:
Silverarc Capital Management LLC — 2.59%
Millennium Management LLC — 1.92%
Marshall Wace LLP — 0.60%
Geode Capital Management LLC — 0.57%
Bank of Montreal Can — 0.46%
Dimensional Fund Advisors LP — 0.32%
Learn More about top institutional investors of Poseida Therapeutics stock.
Which institutional investors are selling Poseida Therapeutics stock?: Within the previous quarter, PSTX stock was sold by these institutional investors:
Silverarc Capital Management LLC
Renaissance Technologies LLC
Atom Investors LP
Bank of Montreal Can
JPMorgan Chase & Co.
Penserra Capital Management LLC
Creative Planning
MCF Advisors LLC
Which institutional investors are buying Poseida Therapeutics stock?: In the previous quarter, PSTX stock was purchased by institutional investors including:
Millennium Management LLC
Marshall Wace LLP
EAM Investors LLC
HRT Financial LP
Citigroup Inc.
Dimensional Fund Advisors LP
GSA Capital Partners LLP
Jane Street Group LLC
Within the last year, these company insiders have bought Poseida Therapeutics stock:
Life Sciences Holdings L Malin (Major Shareholder)
Eric Ostertag (Chairman)
Eric Ostertag (CEO)
Matthew A Spear (Insider)
Learn More investors buying Poseida Therapeutics stock.